Updated:
JPD Capital
JPD Capital is a London-based company that invests in the organic medicine sector, focusing on the medicinal cannabis market. It provides capital raising...
JPD Capital
JPD Capital is a London-based company that invests in the organic medicine sector, focusing on the medicinal cannabis market. It provides capital raising services for companies in the organic medicine supply chain. JPD Capital also offers wealth management and financial advisory services for high net worth individuals and sophisticated investors.
General information
Firm type
Private Equity
Year founded
2023
Location
Region
Europe
Country
United Kingdom
City
London
Corporate office
London, United Kingdom
Frequently asked questions
What investment stages does JPD Capital target?
JPD Capital pursues a multi-stage investment strategy covering early-stage seed rounds and later-stage expansion rounds. This means the firm can back companies at formation, provide growth capital to scaling businesses, and participate in pre-IPO financings. Allocators evaluating the firm should note that this stage-agnostic approach — while offering flexibility — requires a team capable of assessing risk across very different company maturity profiles.
Are there any named principals or investment leads at JPD Capital?
No principals or investment leads have been publicly identified for JPD Capital. The firm's website does not list a team section, and no named individuals are associated with the firm in press coverage or regulatory filings. This opacity is not uncommon for smaller, privately capitalized investment vehicles that do not actively solicit outside investors.
What is JPD Capital's known track record or notable portfolio?
JPD Capital has not publicly disclosed its portfolio companies, exits, or any specific deal track record. Without published case studies or investment announcements, external allocators lack the usual signals — such as named co-investors, realized exits, or fund-level performance data — needed to evaluate the firm's sourcing and execution capabilities.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: